patients underwent multislice computed tomography (MSCT) prior to the procedure. By protocol we pre-defined the same 10 anatomic characteristics by conventional angiography (CA) and MSCT based on previously published independent predictors of failure and our team experience. Two-experienced interventional cardiologist and two imaging specialists, respectively, analysed CTO characteristics. Prospectively, the Japanese-CTO score of complexity was calculated by CA and MSCT. Results: According to the CA-Japanese-CTO score of complexity 47% of lesions were classified as difficult or very difficult. By CA 52% were severe calcified lesions. In most cases (88%) the strategy was antegrade. The total stent length implanted per lesion was of 51.6 AE 20.3mm. In all case last generation DES was implanted. Successful guidewire crossing was 86.4% and the overall success rate was 85.2%. Significant calcification by CA (37.5% vs. 11.5%, p ¼ 0.001) and by MSCT (> 50% cross sectional area) (26.6% vs. 60.0%, p ¼ 0.016) was more prevalent in failed cases. It is important to note a new anatomic characteristic "bad landing zone" (defined as distal vessel just after the CTO exit point, with reference diameter 2mm) by CA (30.5% vs. 63.3%, p ¼ 0.01) was more prevalent in failed cases. By multivariable logistic regression, the only independent predictor of procedural failure was the CA-J-CTO score (odds ratio (OR) 2.5, 95% confidence interval (CI) 1.37-4.59, p¼0.003, for each unit increase in J-CTO score) and silent ischemia as baseline clinic status before PCI-CTO (OR 4.71, CI 1.23-17.95, p¼0.02). Conclusions: According with the results of this prospective study, the Japanese-CTO score of complexity assessed by conventional angiograhy had a significant impact in procedural outcomes.
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Background: At percutaneous coronary intervention (PCI) for chronic total occlusion (CTO), the first guidewire is sometimes inserted into the subintimal space, and in this situation the strategy of intravascular ultrasound (IVUS)-guided wiring, that is, leading the second guidewire into the true lumen under observing by IVUS from subintimal space, was the last procedure because of the absence of the suitable IVUS for this usage. Therefore we have produced CTO specific IVUS, which is named Navifocus WR, with Terumo Corp (Tokyo, Japan). It has a small profile transducer (2.5F) with short length of tip to transducer (9mm) and will be inserted into subintimal space with minimum vessel damage. It has been approved since September in 2012 in Japan. Methods: From September in 2012 to March in 2014, in 16 CTO cases, Navifocus WR was used during the antegrade PCI approach after the first guidewire was inserted into the subintimal space. We succeeded the Navifocus WR-guided antegrade wiring in 10 (63%) of 16 cases. The patients were divided into 2 groups based on the success or failure of Navifocus WR-guided antegrade wiring. Results: The reference diameter was larger in the success group compared to the failure group (2.87AE0.73 mm vs. 2.43AE0.39 mm, P¼0.2). The procedural time of IVUS-guided wiring was significantly shorter in the success group compared to the failure group (20.2AE27.2 minutes vs. 58.5AE41.2 minutes, P¼0.041). In the failure group, we changed to the retrograde approach, etc. and succeeded the PCI procedure in 15 (94%) of 16 cases. Conclusions: At CTO PCI, the success rate of Navifocus WR-guided wiring was acceptable and with the combination of the retrograde approach, etc the high success rate could be achieved.
TCT-215
Impact of Gender on the Outcomes of Percutaneous Coronary Intervention of Chronic Total Occlusions: insights from a multicenter registry Background: We sought to investigate the impact of gender on outcomes of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO). Methods: We examined 2,038 patients who underwent CTO PCI between January 2006 to May 2014 at 6 high volume CTO PCI centers in the United States. Clinical, angiographic and procedural characteristics were compared between male and female patients. Results: Women represented 15% of the CTO PCI population. Significant differences were observed in the baseline characteristics of the study patients (Table) . Women were more likely to have diabetes and to have the right coronary artery as CTO target vessel, and less likely to have prior myocardial infarction or prior coronary artery bypass graft surgery (Table) . Technical and procedural success were higher among women, even though procedural and fluoroscopy time, air kerma radiation exposure, and contrast administration were lower among women. Conclusions: In a large multicenter CTO PCI registry, women constituted 15% of the patients. Technical and procedural success rates were higher among women.
TCT-216
Delayed coverage of drug eluting stents after interventional revascularization of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry Background: Due to low success rates, periprocedural complications and higher risk for restenosis the recanalization of chronic total occlusions of coronary arteries (CTO) remain a challenging task in interventional cardiology. Furthermore several studies have revealed that restenosis and late stent thrombosis are linked to the polymer layer of drug eluting stents. We therefore tested whether drug eluting stents with completely biodegradable polymers are applicable for the treatment of CTO's. Methods: In order to test this hypothesis we retrospectively examined in a monocentric analysis data of 102 CTO patients who were exclusively treated with biolimus eluting stents with fully biodegradable polymers in the past 24 months. CTO was defined as total occlusion of a coronary artery for more than 3 months and TIMI 0 flow in the occluded segment. Primary study endpoint was late loss at the initial occlusion site after 6 months. Secondary clinical endpoints included a composite of cardiac death, myocardial infarction and target vessel revascularization after 6 months (MACE).
Results: 170 CTO procedures were performed in the past 24 months. 138 CTO's were successfully reopened which corresponded to a success rate of 81%. The mean occlusion length of 24 AE 14 mm was treated with an average stent length of 68 AE 30 mm. J-CTO score was 1,8 AE 0,9. 102 of the successfully recanalized CTO patients received biolimus eluting stents with biodegradable polymers. Meanwhile 78 patients have concluded angiographic and clinical 6 months follow up. Late loss at the initial occlusion site was 0,26 AE 0,56 mm. Binary restenosis with the need for reintervention occurred only in 5 patients (6,4%). Cardiac death was documented in 1 patient. In addition to that, one patient suffered from a stent thrombosis with a consecutive myocardial infarction during follow up. Therefore the MACE rate was calculated with 9%.
Conclusions: First results of our monocentric analysis indicate that biolimus eluting stents with fully biodegradable polymers are associated with little late loss and low MACE rates in complex CTO lesions. Future studies in larger, independent patient cohorts are necessary to confirm our results.
TCT-218
Clinical benefit of Multi-detector computed tomography for percutaneous coronary intervention in Chronic Total Occlusions: TACCTO prospective randomized trial Background: Clinical benefit in improving procedural success of a multi-slice computed tomography (MSCT) analysis prior to CTO recanalization is unknown. We performed a prospective randomized trial so as to assess clinical impact of MSCT in improving immediate procedural results. Methods: 106 eligible patients who were scheduled for percutaneous recanalization of a true CTO (Euro-CTO definition) and without contraindications for MSCT were included in the study (TACCTO). All patients underwent MSCT and were randomized (1:1) to be or not to be aware of the result of the MSCT prior to CTO recanalization. MSCT versus conventional coronary angiography (CCA) group were compared regarding immediate procedural success. By protocol, same 10 CTO CCA and MSCTangiography characteristics (based on previously published independent predictors of CTO failure) were pre-defined to be independently analysed. In the MSCT group, CTscan analysis was open to the operator prior to the procedure. A 256-detector system was used for all studies. Post processing was performed with specific software. Results: The mean age was 62 AE 10 years old. According to the Japanese-CTO score of complexity 51% of lesions were classified as difficult or very difficult. 52% were calcified lesions and RCA was the most frequent lesion treated. In most cases (88%) the strategy was anterograde. The total stent length implanted per lesion was of 51.6AE 20.3mm. In all case last generation DES was implanted. Technical success was achieved in 86.8% of the patients in the MSCT group and 84.9% of those in the CCA group (p¼0.75). According to the J-CTO score 2 subgroups of complexity were done: a) easy-intermediate and b) difficult-very difficult. In sub-group a), procedural success was achieved in 100% in both groups (MSCT and CCA). In sub-group b), procedural success was achieved in 80% of the patients in the MSCT group and 75.7% of those in the CCA group (p¼0.85).
Conclusions: According with the results of this prospective randomized trial, in our current era, with new CTO material and techniques, it seems that the information provided by MSCT could be useful, but did not provide a significant impact in procedural outcomes nLAD: OR 0.69, 95%CI 0.5-0.93) were associated with a lower procedural success rate both in LAD and in nLAD subgroups. Lesion tortuosity was an independent predictor of PCI failure exclusively in the LAD-CTO group (OR 0.41 95%CI 0.18-0.93), while a blunt morphology was independently correlated to lower procedural success in the nLAD-CTO group (OR 0.58, . No differences in terms of death, myocardial infarction and urgent pericardiocentesis within 24 hours were recorded between the two groups. Conclusions: Both in the LAD-CTO-PCI and nLAD-CTO-PCI subgroup, severe CTO calcification, lesion length, previous CABG and previous MI were predictors of procedural success. Interestingly, lesion tortuosity and blunt stump were independently correlated to lower procedural success in the LAD-CTO and in the nLAD-CTO subgroup, respectively.
TCT-220
Impact of chronic total occlusion localization on 12-month mortality in patients with non-ST segment elevation myocardial infarction treated with percutaneous coronary intervention Results: In baseline characteristic we observed significant differences in occurrence of diabetes (respectively: 53,5% vs 31,9% vs 25,3 p¼0,007). In-hospital mortality was significantly higher in CTO RCA group (respectively:2.3% vs 0.0% vs 9.3% p¼0.044). The rates of myocardial re-infarction, target vessel revascularization, stroke, major bleeding and average GRACE score during the hospitalization were similar in all analyzed groups. CTO in RCA was associated with increased 12 months mortality in studied groups (respectively: 13.9% vs 4.3 % vs 22.7% p¼0.022), post hoc analysis showed significant difference between CTO RCA and CTO LCx groups (P¼0,006). In multivariate analysis CTO localized in RCA remained independent factor influencing 12 month mortality (HR: 3,82; 95%CI: 1,58-9,20; p:< 0,003).
Conclusions:
In studied population localization of CTO in RCA was associated with worse clinical outcomes and was an independent predictor of 12 month mortality
